© 1988 Oxford University Press
other |
Benign and malignant tumor stages in a mouse keratinocyte line treated with 7,12-dimethylbenz[a]anthracene in vitro
Grace Cancer Drug Center 666 Elm Street, Buffalo, NY 14263, USA
1Department of Pathology, Roswell Park Memorial Institute 666 Elm Street, Buffalo, NY 14263, USA
Stable pre-tumorigenic, benign tumor and squamous cell carcinoma stages have been isolated after treatment of a cloned mouse keratinocyte line with 7,12-dimethylbenz[a]anthracene. Intraperitoneal injection and skin grafting of athymic nude mice were suitable for growth of these well-differentiated tumor cells, whereas subcutaneous injection was not.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
Y. Liu, J. Lagowski, A. Sundholm, A. Sundberg, and M. Kulesz-Martin Microtubule Disruption and Tumor Suppression by Mitogen-Activated Protein Kinase Phosphatase 4 Cancer Res., November 15, 2007; 67(22): 10711 - 10719. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Johnson, J. Lagowski, A. Sundberg, S. Lawson, Y. Liu, and M. Kulesz-Martin p73 Loss Triggers Conversion to Squamous Cell Carcinoma Reversible upon Reconstitution with TAp73{alpha} Cancer Res., August 15, 2007; 67(16): 7723 - 7730. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Albor, S. El-Hizawi, E. J. Horn, M. Laederich, P. Frosk, K. Wrogemann, and M. Kulesz-Martin The Interaction of Piasy with Trim32, an E3-Ubiquitin Ligase Mutated in Limb-girdle Muscular Dystrophy Type 2H, Promotes Piasy Degradation and Regulates UVB-induced Keratinocyte Apoptosis through NF{kappa}B J. Biol. Chem., September 1, 2006; 281(35): 25850 - 25866. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Horn, A. Albor, Y. Liu, S. El-Hizawi, G. E. Vanderbeek, M. Babcock, G. T. Bowden, H. Hennings, G. Lozano, W. C. Weinberg, et al. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties Carcinogenesis, February 1, 2004; 25(2): 157 - 167. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Knights, Y. Liu, E. Appella, and M. Kulesz-Martin Defective p53 Post-translational Modification Required for Wild Type p53 Inactivation in Malignant Epithelial Cells with mdm2 Gene Amplification J. Biol. Chem., December 26, 2003; 278(52): 52890 - 52900. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, Y. Liu, M. Mori, and M. Kulesz-Martin Gene expression profiling of initiated epidermal cells with benign or malignant tumor fates Carcinogenesis, April 1, 2002; 23(4): 635 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Witkowski, G.T. Bowden, R. B. Nagle, and A. E. Cress Altered surface expression and increased turnover of the {alpha}6{beta}4 integrin in an undifferentiated carcinoma Carcinogenesis, February 1, 2000; 21(2): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Cmarik, H. Min, G. Hegamyer, S. Zhan, M. Kulesz-Martin, H. Yoshinaga, S. Matsuhashi, and N. H. Colburn Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation PNAS, November 23, 1999; 96(24): 14037 - 14042. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, H. Huang, Z. Miner, and M. Kulesz-Martin Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53 PNAS, August 19, 1997; 94(17): 8982 - 8987. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. L. Davis, I. Rabinovitz, B. W. Futscher, M. Schnolzer, F. Burger, Y. Liu, M. Kulesz-Martin, and A. E. Cress Identification of a Novel Structural Variant of the alpha 6 Integrin J. Biol. Chem., July 6, 2001; 276(28): 26099 - 26106. [Abstract] [Full Text] [PDF] |
||||



